Background There is a lack of research addressing associations of antidiabetic drug combinations with COVID-19 deaths. We examined whether adding common second-line agents to metformin was associated with COVID-19 mortality risk to inform clinical decision-ma…
Introduction
It is estimated that over 500 million people aged 2079 have diabetes mellitus and every year, 6.7 million people die due to diabetes [1]. During the COVID-19 pandemic, people with diabe… [+27931 chars]
